Marcin Straburzyński
Dźwierzuty, Warmian-Masurian Voivodeship, 12-120, Poland
NCT Number: NCT06127186
The goal of this longitudinal study is to assess headache and facial pain features in patients with upper respiratory tract infections (URTI). The main question it aims to answer are:
1. What is the phenotype of headache / facial pain in URTIs 2. Does the above mentioned phenotype is associated with:
1. aetiologic factor (virus), 2. type of URTI 3. headache/facial pain experienced by patients in the past.
Participants will:
* answer standardized questions, * undergo physical examination, * have a swab test performend for antigens of common viruses causing URTI.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Dźwierzuty, Warmian-Masurian Voivodeship, 12-120, Poland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention except for a routine examination and viral testing is planned.
Other names: Standarised questionnaire, Physical examination
Time frame: A single assessment during primary care physician office 1 day visit.
Percentage of patients with one of the specified pain phenotypes (migraine-like/tension-type-like/trigeminal cephalalgia-like)
Marcin Straburzynski
Other
Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections - a Cross-sectional Study in Primary Care Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT04155892
Infections, Respiratory Tract Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT05577065
Infections, Respiratory Tract Diseases
Cork, Ireland
View Trial Details